More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Ensign (NASDAQ: ENSG)
Investigations, Securities
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating The Ensign Group (NASDAQ: ENSG) (“Ensign” or the “Company”) for potential violations of the […]
Alignment Healthcare (NASDAQ: ALHC)
Investigations, Securities
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) (“Alignment” or the “Company”) for potential violations of the […]
Summit Therapeutics Inc. (NASDAQ: SMMT)
Investigations, Securities
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating whether certain officers and directors of Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the […]
News
Lowey Secures $105 Million Recovery for BBSW Investors
On December 10, 2021, Plaintiffs in Dennis, et al. v. JPMorgan Chase & Co., et al., No. 16-cv-06496 (S.D.N.Y.) announced that they entered settlement agreements with Morgan Stanley, Morgan Stanley Australia Limited, Australia and New Zealand Banking Group…
Blog
Rule 10b5-1 Trading Plans Under Scrutiny: Are They Subject To Insider Trading Abuse?
The U.S. Securities and Exchange Commission (SEC) is working to overhaul the rule that protects corporate executives from insider trading accusations when they buy or sell their company’s stocks. Executives are regularly exposed to material nonpublic information (MNPI) and would be at risk of…